Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
American Association for Geriatric Psychiatry. Geriatrics and mental health—the facts. http://www.aagpgpa.org/prof/facts_mh.asp.
[2.]
Centers for Medicare and Medicaid Services. Resident Assessment Instrument: Appendix C-17 Psychotropic Drug Use, 2002.
[3.]
D.V. Jeste.
Comparison of conventional vs. atypical antipsychotic drugs: Focus on elderly patients.
Long-Term Care Forum, 1 (2002), pp. 10-13
[4.]
P.A. Rochon, et al.
Antipsychotic therapy and short-term serious events in older adults with dementia.
Archives of Internal Medicine, 168 (2008), pp. 1090-1096
[5.]
P.E. Lee, et al.
Atypical antipsychotic drugs in the treatment of behavioral and psychological symptoms of dementia: Systematic review.
BMJ, 329 (2004), pp. 75
[6.]
L.S. Schneider, et al.
Risk of death with atypical antipsychotic drug treatment for dementia: Meta-analysis of randomized placebo-controlled trials.
JAMA, 294 (2005), pp. 1934-1943
[7.]
Centers for Medicare and Medicaid Services. State Operations Manual, Appendix PP: Interpretive Guidelines of Long-Term Care Facilities: Unnecessary Drugs. 483.25(l), revised December 2006, 272–338. http://www.cms.hhs.gov/manuals/downloads/som107_Appendicestoc.pdf.
[8.]
D.S. Chutka, et al.
Inappropriate medications for elderly patients.
Mayo Clinic Proceedings, 79 (2004), pp. 122-139
[9.]
B.L. Saltz, et al.
Side effects of antipsychotic drugs: Avoiding and minimizing their impact in elderly patients.
Postgraduate Medicine, 107 (2000), pp. 169-178
[10.]
Clinical Handbook of Psychotropic Drugs, 16th,
Copyright © 2009. Lippincott Williams & Wilkins